Identification of a sperm protein 17 CTL epitope restricted by HLA-A1

International Journal of Cancer

Volumn 107, Issue 5, 2003, Pages 863-865

  Chiriva Internati, Maurizio ^a,b   Wang, Zhiqing ^a,b   Pochopien, Stephanie ^a,b   Salati, Emanuela ^a,b   Lim, Seah H ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Harrington Cancer Center   (United States)

Author keywords

CTL epitopes; HLA A1; Sperm protein 17

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A1 ANTIGEN; SPERM PROTEIN 17; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPERM; T LYMPHOCYTE ACTIVATION;

CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES; HLA-A1 ANTIGEN; HUMANS; MALE; PEPTIDE FRAGMENTS; SPERMATOZOA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0242268630     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11486     Document Type: Article

References (10)

1. Kong M, Richardson RT, Widgren EE, O'Rand MG. Sequence and localization of the mouse autoantigenic protein, Sp17. Biol Reprod 1995;53:579-90.
2. Lacy HM, Sanderson RD. Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood 2001;98:2160-5.
3. Lim SH, Wang Z, Chiriva-Internati M, Xue Y. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 2001;97: 1508-10.
4. Chiriva-Internati M, Wang Z, Salati E, Timmins P, Lim SH. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Cancer 2002;94:2447-53.
5. De Jong A, Buchli R, Robbins D. Characterization of sperm protein 17 in human somatic and neoplastic tissue. Cancer Lett 2002;86:201.
6. Chiriva-Internati M, Wang Z, Xue Y, Bumm K, Hahn A, Lim SH. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus myeloma effect without increasing graft-versus-host disease risk. Eur J Immunol 2001;31:2277-83.
7. Chiriva-Internati M, Wang Z, Salafi E, Wroblewski D, Lim SH. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumor-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Scand J Immunol 2002;56:429-33.
8. Chiriva-Internati M, Wang Z, Salati E, Bumm K, Barlogie B, Lim SH. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Blood 2002;100:961-5.
9. Lim SH, Bailey-Wood R. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. Int J Cancer 1999;83:215-22.
10. + lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J Virol 1999;73:5402-10.